Product Categories
| Country: | China |
|---|---|
| Tel: | 13720134139 086-15871494362 |
| Mobile: | 13720134139 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| TGX-221 | C21H24N4O2 | 663619-89-4 | Details |
| PHA-767491(HCl) | C12H11N3O | 845714-00-3 | Details |
| Ganetespib | C20H20N4O3 | 888216-25-9 | Details |
| Moclobemide (Ro 111163) | C13H17ClN2O2 | 71320-77-9 | Details |
| Ulocuplumab | 1375830-34-4 | Details |
| Brontictuzumab | 1447814-75-6 | Details |
| Research Grade Obexelimab | 1690307-05-1 | Details |
| Vandortuzumab Vedotin | 1471985-92-8 | Details |
| Amivantamab | 2171511-58-1 | Details |
| GSK 429286A | C21H16F4N4O2 | 864082-47-3 | Details |
| Sparsentan | C32H40N4O5S | 254740-64-2 | Details |
| VR23 | C19H16ClN5O6S | 1624602-30-7 | Details |
| Anetumab Ravtansine | 1375258-01-7 | Details |
| Fletikumab | 1357158-22-5 | Details |
| Abituzumab | 1105038-73-0 | Details |
| Lenzilumab | 1229575-09-0 | Details |
| Research Grade Tafasitamab | 1422527-84-1 | Details |
| CID 755673 | C12H11NO3 | 521937-07-5 | Details |
| HMN-214 | C22H20N2O5S | 173529-46-9 | Details |
| LMK-235 | C15H22N2O4 | 1418033-25-6 | Details |
| SB 366791 | C16H14ClNO2 | 472981-92-3 | Details |
| Tirzepatide | C225H348N48O68 | 2023788-19-2 | Details |
| Tarextumab | 1359940-55-8 | Details |
| Anifrolumab | 1326232-46-5 | Details |
| Emibetuzumab | 1365287-97-3 | Details |
| Lumretuzumab | 1448327-63-6 | Details |
| SKF38393 HCl | C16H17NO2 | 62717-42-4 | Details |
| Eldelumab | 946414-98-8 | Details |
| Ralpancizumab | 1407495-04-8 | Details |
| Denintuzumab Mafodotin | 1399672-02-6 | Details |
| Lacutamab | 2187368-16-5 | Details |
| semaglutide | C42H69N9O14S | 99291-20-0 | Details |
| GW0742 | C21H17F4NO3S2 | 317318-84-6 | Details |
| A66 | C17H23N5O2S2 | 1166227-08-2 | Details |
| Apoptozole | C33H25F6N3O3 | 1054543-47-3 | Details |
| APS-2-79 | C23H22ClN3O3 | 2002381-31-7 | Details |
| mu-conotoxin | C92H139N35O28S6 | 936616-33-0 | Details |
| AG 490 | C17H14N2O3 | 133550-30-8 | Details |
| Dapirolizumab Pegol | 1416147-64-2 | Details |
| Coltuximab Ravtansine | 1269764-99-9 | Details |
| Firivumab | 1443004-15-6 | Details |
| Lokivetmab | 1533403-95-0 | Details |
| Kartogenin | C20H15NO3 | Details |
| Oprozomib;ONX-0912 | C25H32N4O7S | 935888-69-0 | Details |
| FPS-ZM1 | C20H22ClNO | 945714-67-0 | Details |
| KC7F2 | C16H16Cl4N2O4S4 | 927822-86-4 | Details |
| HLCL-61 | C23H25ClN2O | 1158279-20-9 | Details |
| Avelumab | 1537032-82-8 | Details |
| Reversine | C21H27N7O | 656820-32-5 | Details |
| Scriptaid | C18H18N2O4 | 287383-59-9 | Details |
| Tovetumab | 1243266-04-7 | Details |
| Enfortumab Vedotin | 1346452-25-2 | Details |
| Pasotuxizumab | 1442657-12-6 | Details |
| Begelomab | 1403744-56-8 | Details |
| BLU-945 | C28H37FN6O3S | 2660250-10-0 | Details |
| SW-033291 | C21H20N2OS3 | 459147-39-8 | Details |
| Daprodustat;GSK1278863 | C19H27N3O6 | 960539-70-2 | Details |
| Idarucizumab | 1362509-93-0 | Details |
| Aducanumab | 1384260-65-4 | Details |
| Bimekizumab | 1418205-77-2 | Details |
| Guselkumab | 1350289-85-8 | Details |
| Tosatoxumab | 1374419-41-6 | Details |
| Bococizumab | 1407495-02-6 | Details |
| Vanucizumab | 1448221-05-3 | Details |
| Vitamin K2 (Mk7) | C46H64O2 | 2124-57-4 | Details |
| GW2580 | C20H22N4O3 | 870483-87-7 | Details |
| Vidofludimus;4SC-101 | C20H18FNO4 | 717824-30-1 | Details |
| Stattic | C8H5NO4S | 19983-44-9 | Details |
| AZD9496 | C25H25F3N2O2 | 1639042-08-2 | Details |
| ON123300 | C24H27N7O | 1357470-29-1 | Details |
| CC122 | C14H14N4O3 | 1015474-32-4 | Details |
| BMS-986165 | C20H22N8O3 | 1609392-27-9 | Details |
| Otlertuzumab | 1372645-37-8 | Details |
| Go 6983 | C26H26N4O3 | 133053-19-7 | Details |
| Sofituzumab Vedotin | 1418200-58-4 | Details |
| Ontuxizumab | 946415-62-9 | Details |
| Remtolumab | 1791410-27-9 | Details |
| Evinacumab | 1446419-85-7 | Details |
| 3-Piperidinecarboxamide, N-(4,6-difluoro-2-benzothiazolyl)-1-[2-(dimethylamino)ethyl]- | C17H22F2N4OS | 2747162-85-0 | Details |
| WP 1066 | C17H14BrN3O | 857064-38-1 | Details |
| BAY-57-1293;Pritelivir | C18H18N4O3S2 | 348086-71-5 | Details |
| Tazemetostat (EPZ-6438) | C34H44N4O4 | 1403254-99-8 | Details |
| BLU-9931 | C26H22Cl2N4O3 | 1538604-68-0 | Details |
| Durvalumab | 1428935-60-7 | Details |
| Atezolizumab | 1380723-44-3 | Details |
| Varlilumab | 1393344-72-3 | Details |
| dinutuximab | 1363687-32-4 | Details |
| UCB-9260 | C26H25N5O | 1515888-53-5 | Details |
| Vantictumab | 1345009-45-1 | Details |
| Lifastuzumab Vedotin | 1401812-88-1 | Details |
| Lulizumab Pegol | 1421830-13-8 | Details |
| Imalumab | 1430205-07-4 | Details |
| PD 123319 ditrifluoroacetate | C33H33F3N4O5 | 136676-91-0 | Details |
| SB 742457 | C19H19N3O2S | 607742-69-8 | Details |
| SH-4-54 | C29H27F5N2O5S | 1456632-40-8 | Details |
| Vobarilizumab | 1628814-88-9 | Details |
| Codrituzumab | 1365267-33-9 | Details |
| Margetuximab | 1350624-75-7 | Details |
| Abrilumab | 1342290-43-0 | Details |
| Emactuzumab | 1448221-67-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 | ||||